ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
PRO81 Is EU Orphan Medicine Status Working? a Retrospective Analysis of Orphan Drug Reimbursement in England
Value in Health
◽
10.1016/j.jval.2020.08.1817
◽
2020
◽
Vol 23
◽
pp. S704
Author(s):
S. Coyle
◽
J. Mumford
◽
G. Roberts
Keyword(s):
Retrospective Analysis
◽
Orphan Drug
◽
Drug Reimbursement
Download Full-text
Related Documents
Cited By
References
A Retrospective Analysis of Drug Reimbursement Decisions in Ireland: A Multi Criteria Decision Analysis Approach
Value in Health
◽
10.1016/j.jval.2013.08.820
◽
2013
◽
Vol 16
(7)
◽
pp. A465
Author(s):
S. Schmitz
◽
L. McCullagh
◽
R. Adams
◽
M. Barry
◽
C. Walsh
Keyword(s):
Decision Analysis
◽
Retrospective Analysis
◽
Analysis Approach
◽
Drug Reimbursement
◽
Multi Criteria Decision Analysis
Download Full-text
Efficacy of panitumumab and cetuximab in elderly patients (aged ≥75) with chemotherapy-refractory wild-type KRAS exon 2 metastatic colorectal cancer (mCRC): Retrospective analysis of data from nationwide drug-reimbursement-access program
Annals of Oncology
◽
10.1093/annonc/mdx393.052
◽
2017
◽
Vol 28
◽
pp. v178
Author(s):
M. Swierkowski
◽
A. Ptak-Chmielewska
◽
A. Sliwczynski
◽
T. Czeleko
◽
Z. Teter
◽
...
Keyword(s):
Colorectal Cancer
◽
Elderly Patients
◽
Metastatic Colorectal Cancer
◽
Retrospective Analysis
◽
Wild Type
◽
Exon 2
◽
Drug Reimbursement
◽
Access Program
◽
Kras Exon
Download Full-text
Which Factors Enhance Positive Drug Reimbursement Recommendation in Scotland? A Retrospective Analysis 2006–2013
Value in Health
◽
10.1016/j.jval.2014.12.008
◽
2015
◽
Vol 18
(2)
◽
pp. 284-291
◽
Cited By ~ 21
Author(s):
Mata Charokopou
◽
Istvan M. Majer
◽
Johan de Raad
◽
Stefan Broekhuizen
◽
Maarten Postma
◽
...
Keyword(s):
Retrospective Analysis
◽
Drug Reimbursement
Download Full-text
Efficacy of panitumumab and cetuximab in patients with chemotherapy-refractory wild-type KRAS exon 2 metastatic colorectal cancer (mCRC): Retrospective analysis of data from nationwide drug-reimbursement-access program
Annals of Oncology
◽
10.1093/annonc/mdx393.054
◽
2017
◽
Vol 28
◽
pp. v179
Author(s):
M. Swierkowski
◽
A. Ptak-Chmielewska
◽
A. Sliwczynski
◽
T. Czeleko
◽
Z. Teter
◽
...
Keyword(s):
Colorectal Cancer
◽
Metastatic Colorectal Cancer
◽
Retrospective Analysis
◽
Wild Type
◽
Exon 2
◽
Drug Reimbursement
◽
Access Program
◽
Kras Exon
Download Full-text
Orphan Drug Reimbursement In Europe: Do Less Stringent Regulatory Requirements Translate Into Less Favourable Reimbursement?
Value in Health
◽
10.1016/j.jval.2017.08.373
◽
2017
◽
Vol 20
(9)
◽
pp. A464
Author(s):
E Anastasaki
◽
R Macaulay
Keyword(s):
Orphan Drug
◽
Regulatory Requirements
◽
Drug Reimbursement
Download Full-text
Similarities and Differences In Orphan Drug Reimbursement In 16 European Countries
Value in Health
◽
10.1016/j.jval.2015.09.2008
◽
2015
◽
Vol 18
(7)
◽
pp. A677-A678
Author(s):
K Falk
◽
A Brown
◽
E Faria-Billinton
◽
M Martensson
◽
G Murray
◽
...
Keyword(s):
Orphan Drug
◽
European Countries
◽
Drug Reimbursement
◽
Similarities And Differences
Download Full-text
PRO101 ORPHAN DRUG REIMBURSEMENT IN ENGLAND AND IMPLICATIONS FOR PATIENT ACCESS
Value in Health
◽
10.1016/j.jval.2019.09.2431
◽
2019
◽
Vol 22
◽
pp. S859
Author(s):
S. Walker
◽
H. Lilley
◽
R. Payne
◽
D. Fountain
Keyword(s):
Orphan Drug
◽
Patient Access
◽
Drug Reimbursement
Download Full-text
A Review of Rare Disease Policies and Orphan Drug Reimbursement Systems in 12 Eurasian Countries
Frontiers in Public Health
◽
10.3389/fpubh.2019.00416
◽
2020
◽
Vol 7
◽
Cited By ~ 9
Author(s):
Marcin Czech
◽
Aleksandra Baran-Kooiker
◽
Kagan Atikeler
◽
Maria Demirtshyan
◽
Kamilla Gaitova
◽
...
Keyword(s):
Rare Disease
◽
Orphan Drug
◽
Drug Reimbursement
Download Full-text
Economic Evaluation And Cost-Effectiveness Threshold In Practice Of Decision-Making On Orphan Drug Reimbursement In Poland
Value in Health
◽
10.1016/j.jval.2017.08.936
◽
2017
◽
Vol 20
(9)
◽
pp. A563-A564
Author(s):
K Skora
◽
T Bochenek
◽
J Augustynska
◽
J Walczak
Keyword(s):
Decision Making
◽
Economic Evaluation
◽
Cost Effectiveness
◽
Orphan Drug
◽
Drug Reimbursement
◽
Cost Effectiveness Threshold
◽
Effectiveness Threshold
Download Full-text
PNS185 Solutions to the Comparator Question in the Absence of Licensed Comparators? a Retrospective Analysis of Orphan Drug and GENE Therapy Reimbursement in EU5 Markets
Value in Health
◽
10.1016/j.jval.2020.08.1629
◽
2020
◽
Vol 23
◽
pp. S671-S672
Author(s):
A. Mumford
◽
B. English
◽
L. Sopena
◽
R. Munetsi
Keyword(s):
Gene Therapy
◽
Retrospective Analysis
◽
Orphan Drug
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close